Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$56.80 2.04 (3.73%) as of 4:30 Wed 5/22


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 4.01(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 61,438 159,721 184,721 409,721
Total Sell Value $4,291,798 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 7 12 13 22
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 483
  Page 18 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-27 4 AS $16.78 $37,023 D/D (2,206) 134,047     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-27 4 OE $1.81 $3,993 D/D 2,206 136,253     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-26 4 AS $16.76 $53,641 D/D (3,200) 180,495     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-26 4 AS $16.74 $54,816 D/D (3,275) 134,047     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-26 4 OE $1.81 $5,928 D/D 3,275 137,322     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-25 4 AS $16.87 $80,990 D/D (4,800) 183,695     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-25 4 AS $16.87 $86,290 D/D (5,115) 134,047     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-25 4 OE $1.81 $9,258 D/D 5,115 139,162     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-24 4 AS $16.44 $57,897 D/D (3,522) 188,495     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-24 4 AS $16.46 $57,619 D/D (3,500) 134,047     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-24 4 OE $1.81 $6,335 D/D 3,500 137,547     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-21 4 AS $17.02 $51,222 D/D (3,010) 192,017     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-21 4 AS $17.01 $51,033 D/D (3,000) 134,047     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-21 4 OE $1.81 $5,430 D/D 3,000 137,047     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-04-20 4 AS $17.37 $39,852 D/D (2,294) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-04-20 4 OE $1.81 $4,152 D/D 2,294 1,217,299     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-20 4 AS $17.36 $48,621 D/D (2,800) 134,047     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-20 4 OE $1.81 $5,068 D/D 2,800 136,847     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-20 4 AS $17.37 $51,025 D/D (2,937) 195,027     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-04-19 4 AS $17.57 $854,066 D/D (47,706) 1,215,005     -
   Novak Rodger Chief Executive Officer   •       •      –    2017-04-19 4 OE $1.81 $86,348 D/D 47,706 1,262,711     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-19 4 AS $17.54 $129,754 D/D (7,258) 134,047     -
   Kulkarni Samarth Chief Business Officer   •       –      –    2017-04-19 4 OE $1.81 $13,137 D/D 7,258 141,305     -
   Dylan-Hyde Tyler Chief Legal Officer   •       –      –    2017-04-19 4 AS $17.49 $129,165 D/D (7,240) 197,964     -
   Emster Kurt Von Director   –       •      –    2016-10-24 4 B $14.00 $784,000 I/I 56,000 2,601,814 2.1     -
  483 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us